Evaluation of the accuracy of a multi-infection screening test based on a multiplex immunoassay targeting imported diseases common in migrant populations

Background: We aimed to evaluate the performance of a novel multiplex serological assay, able to simultaneously detect IgG of six infections, as a screening tool for imported diseases in migrants. Methods: Six panels of 40 (n = 240) anonymized serum samples with confirmed infections were used as pos...

Full description

Bibliographic Details
Main Authors: Ruth Aguilar, Angeline Cruz, Alfons Jiménez, Alex Almuedo, Carme Roca Saumell, Marina Gigante Lopez, Oriol Gasch, Gemma Falcó, Ana Jiménez-Lozano, Angela Martínez-Perez, Consol Sanchez-Collado, Andrea Tedesco, Manuel Carlos López, María Jesús Pinazo, Thais Leonel, Zeno Bisoffi, Anna Färnert, Carlota Dobaño, Ana Requena-Méndez
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Travel Medicine and Infectious Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1477893923001412
_version_ 1797351546171686912
author Ruth Aguilar
Angeline Cruz
Alfons Jiménez
Alex Almuedo
Carme Roca Saumell
Marina Gigante Lopez
Oriol Gasch
Gemma Falcó
Ana Jiménez-Lozano
Angela Martínez-Perez
Consol Sanchez-Collado
Andrea Tedesco
Manuel Carlos López
María Jesús Pinazo
Thais Leonel
Zeno Bisoffi
Anna Färnert
Carlota Dobaño
Ana Requena-Méndez
author_facet Ruth Aguilar
Angeline Cruz
Alfons Jiménez
Alex Almuedo
Carme Roca Saumell
Marina Gigante Lopez
Oriol Gasch
Gemma Falcó
Ana Jiménez-Lozano
Angela Martínez-Perez
Consol Sanchez-Collado
Andrea Tedesco
Manuel Carlos López
María Jesús Pinazo
Thais Leonel
Zeno Bisoffi
Anna Färnert
Carlota Dobaño
Ana Requena-Méndez
author_sort Ruth Aguilar
collection DOAJ
description Background: We aimed to evaluate the performance of a novel multiplex serological assay, able to simultaneously detect IgG of six infections, as a screening tool for imported diseases in migrants. Methods: Six panels of 40 (n = 240) anonymized serum samples with confirmed infections were used as positive controls to assess the multiplex assay's sensitivity. One panel of 40 sera from non-infected subjects was used to estimate the seropositivity cutoffs, and 32 non-infected sera were used as negative controls to estimate each serology's sensitivity and specificity. The multi-infection screening test was validated in a prospective cohort of 48 migrants from endemic areas.The sensitivity of the Luminex assay was calculated as the proportion of positive results over all positive samples identified by reference tests. The specificity was calculated using 32 negative samples. Uncertainty was quantified with 95 % confidence intervals using receiver operating characteristic analyses. Results: The sensitivity/specificity were 100 %/100 % for HIV (gp41 antigen), 97.5 %/100 % for Hepatitis B virus (HBV-core antigen), 100 %/100 % for Hepatitis C virus (HCV-core antigen), 92.5 %/90.6 % for strongyloidiasis [31-kDa recombinant antigen (NIE)], 97.5 %/100 % for schistosomiasis (combined serpin Schistosoma mansoni and S.haematobium antigens) and 95 %/90.6 % for Chagas disease [combined Trypanosoma cruzi kinetoplastid membrane protein-11 (KMP11) and paraflagellar rod proteins 2 (PFR2) antigens].In the migrant cohort, antibody response to the combination of the T.cruzi antigens correctly identified 100 % individuals, whereas HBV-core antigen correctly identified 91.7 % and Strongyloides-NIE antigen 86.4 %. Conclusions: We developed a new, robust and accurate 8-plex Luminex assay that could facilitate the implementation of screening programmes targeting migrant populations.
first_indexed 2024-03-08T13:02:02Z
format Article
id doaj.art-2ffdd2faeff744d1b86a54c5229f9c97
institution Directory Open Access Journal
issn 1873-0442
language English
last_indexed 2024-03-08T13:02:02Z
publishDate 2024-01-01
publisher Elsevier
record_format Article
series Travel Medicine and Infectious Disease
spelling doaj.art-2ffdd2faeff744d1b86a54c5229f9c972024-01-19T04:54:06ZengElsevierTravel Medicine and Infectious Disease1873-04422024-01-0157102681Evaluation of the accuracy of a multi-infection screening test based on a multiplex immunoassay targeting imported diseases common in migrant populationsRuth Aguilar0Angeline Cruz1Alfons Jiménez2Alex Almuedo3Carme Roca Saumell4Marina Gigante Lopez5Oriol Gasch6Gemma Falcó7Ana Jiménez-Lozano8Angela Martínez-Perez9Consol Sanchez-Collado10Andrea Tedesco11Manuel Carlos López12María Jesús Pinazo13Thais Leonel14Zeno Bisoffi15Anna Färnert16Carlota Dobaño17Ana Requena-Méndez18Barcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Carrer Roselló 132, 08036, Barcelona, SpainBarcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Carrer Roselló 132, 08036, Barcelona, SpainBarcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Carrer Roselló 132, 08036, Barcelona, Spain; Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP), Avenida Monforte de Lemos 3-5, 28029, Madrid, SpainBarcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Carrer Roselló 132, 08036, Barcelona, SpainCentre d'Atenció Primaria El Clot, Institut Català de la Salut (ICS), Carrer Concilio de Trento 25, 08018, Barcelona, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Carrer Casanova, 143, 08036, Barcelona, SpainCentre d'Atenció Primaria Center Numància, Institut Català de la Salut (ICS), Carrer Numància 23, 08029, Barcelona, SpainInfectious Diseases Department, Hospital Universitari Parc Taulí. Institut d’Investigació i Innovació Parc Taulí. Universitat Autònoma de Barcelona, Parc Taulí, 1, 08208, Sabadell-Barcelona, SpainCentre d'Atenció Primaria Sant Miquel, Institut Català de la Salut (ICS), Carrer Francesc Macià i Llussà, 154, 08401, Granollers-Barcelona, SpainCentre d'Atenció Primaria Adrià 5A Marc Aureli, Institut Català de la Salut (ICS), Carrer Vallmajor, 34, 08021, Barcelona, SpainCentre d'Atenció Primaria Casanova. Consorci d'Atenció Primària de Salut de l'Eixample (CAPSBE) Casanova. Carrer Rosselló 161, 08036, Barcelona, SpainCentre d'Atenció Primaria Torelló, Institut Català de la Salut (ICS), Avenida Pompeu Fabra, 8, 08570, Torelló-Barcelona, SpainDepartment of Infectious Tropical diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Via Sempreboni 5, 37024, Negrar di Valpolicella, ItalySpanish National Research Council (IPBLN-CSIC), Avenida del Conocimiento 17, Parque Tecnológico de Ciencias de la Salud, 18016, Granada, SpainBarcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Carrer Roselló 132, 08036, Barcelona, Spain; Biomedical Research Networking Center (CIBER) of Infectious Diseases, Carlos III Health Institute (CIBERINFEC, ISCIII), Carrer Melchor Fernández Almagro, 3, 28029, Madrid, SpainLiver Unit, Hospital Clínic, University of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Biomedical Research Networking Center of Hepatic and Digestive Diseases (CIBEREHD), Carrer Villarroel, 170, 08036, Barcelona, SpainDepartment of Infectious Tropical diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Via Sempreboni 5, 37024, Negrar di Valpolicella, ItalyDepartment of Medicine Solna, Karolinska Institutet, Solnavägen 1, 17177, Solna-Stockholm, Sweden; Department of Infectious Diseases, Karolinska University Hospital, Solnavägen 1, 17177, Solna-Stockholm, SwedenBarcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Carrer Roselló 132, 08036, Barcelona, Spain; Biomedical Research Networking Center (CIBER) of Infectious Diseases, Carlos III Health Institute (CIBERINFEC, ISCIII), Carrer Melchor Fernández Almagro, 3, 28029, Madrid, SpainBarcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Carrer Roselló 132, 08036, Barcelona, Spain; Biomedical Research Networking Center (CIBER) of Infectious Diseases, Carlos III Health Institute (CIBERINFEC, ISCIII), Carrer Melchor Fernández Almagro, 3, 28029, Madrid, Spain; Department of Medicine Solna, Karolinska Institutet, Solnavägen 1, 17177, Solna-Stockholm, Sweden; Department of Infectious Diseases, Karolinska University Hospital, Solnavägen 1, 17177, Solna-Stockholm, Sweden; Corresponding author. Karolinska Institutet, Department of Medicine Solna, Sweden.Background: We aimed to evaluate the performance of a novel multiplex serological assay, able to simultaneously detect IgG of six infections, as a screening tool for imported diseases in migrants. Methods: Six panels of 40 (n = 240) anonymized serum samples with confirmed infections were used as positive controls to assess the multiplex assay's sensitivity. One panel of 40 sera from non-infected subjects was used to estimate the seropositivity cutoffs, and 32 non-infected sera were used as negative controls to estimate each serology's sensitivity and specificity. The multi-infection screening test was validated in a prospective cohort of 48 migrants from endemic areas.The sensitivity of the Luminex assay was calculated as the proportion of positive results over all positive samples identified by reference tests. The specificity was calculated using 32 negative samples. Uncertainty was quantified with 95 % confidence intervals using receiver operating characteristic analyses. Results: The sensitivity/specificity were 100 %/100 % for HIV (gp41 antigen), 97.5 %/100 % for Hepatitis B virus (HBV-core antigen), 100 %/100 % for Hepatitis C virus (HCV-core antigen), 92.5 %/90.6 % for strongyloidiasis [31-kDa recombinant antigen (NIE)], 97.5 %/100 % for schistosomiasis (combined serpin Schistosoma mansoni and S.haematobium antigens) and 95 %/90.6 % for Chagas disease [combined Trypanosoma cruzi kinetoplastid membrane protein-11 (KMP11) and paraflagellar rod proteins 2 (PFR2) antigens].In the migrant cohort, antibody response to the combination of the T.cruzi antigens correctly identified 100 % individuals, whereas HBV-core antigen correctly identified 91.7 % and Strongyloides-NIE antigen 86.4 %. Conclusions: We developed a new, robust and accurate 8-plex Luminex assay that could facilitate the implementation of screening programmes targeting migrant populations.http://www.sciencedirect.com/science/article/pii/S1477893923001412MigrantsScreeningLuminexIgGSensitivitySpecificity
spellingShingle Ruth Aguilar
Angeline Cruz
Alfons Jiménez
Alex Almuedo
Carme Roca Saumell
Marina Gigante Lopez
Oriol Gasch
Gemma Falcó
Ana Jiménez-Lozano
Angela Martínez-Perez
Consol Sanchez-Collado
Andrea Tedesco
Manuel Carlos López
María Jesús Pinazo
Thais Leonel
Zeno Bisoffi
Anna Färnert
Carlota Dobaño
Ana Requena-Méndez
Evaluation of the accuracy of a multi-infection screening test based on a multiplex immunoassay targeting imported diseases common in migrant populations
Travel Medicine and Infectious Disease
Migrants
Screening
Luminex
IgG
Sensitivity
Specificity
title Evaluation of the accuracy of a multi-infection screening test based on a multiplex immunoassay targeting imported diseases common in migrant populations
title_full Evaluation of the accuracy of a multi-infection screening test based on a multiplex immunoassay targeting imported diseases common in migrant populations
title_fullStr Evaluation of the accuracy of a multi-infection screening test based on a multiplex immunoassay targeting imported diseases common in migrant populations
title_full_unstemmed Evaluation of the accuracy of a multi-infection screening test based on a multiplex immunoassay targeting imported diseases common in migrant populations
title_short Evaluation of the accuracy of a multi-infection screening test based on a multiplex immunoassay targeting imported diseases common in migrant populations
title_sort evaluation of the accuracy of a multi infection screening test based on a multiplex immunoassay targeting imported diseases common in migrant populations
topic Migrants
Screening
Luminex
IgG
Sensitivity
Specificity
url http://www.sciencedirect.com/science/article/pii/S1477893923001412
work_keys_str_mv AT ruthaguilar evaluationoftheaccuracyofamultiinfectionscreeningtestbasedonamultipleximmunoassaytargetingimporteddiseasescommoninmigrantpopulations
AT angelinecruz evaluationoftheaccuracyofamultiinfectionscreeningtestbasedonamultipleximmunoassaytargetingimporteddiseasescommoninmigrantpopulations
AT alfonsjimenez evaluationoftheaccuracyofamultiinfectionscreeningtestbasedonamultipleximmunoassaytargetingimporteddiseasescommoninmigrantpopulations
AT alexalmuedo evaluationoftheaccuracyofamultiinfectionscreeningtestbasedonamultipleximmunoassaytargetingimporteddiseasescommoninmigrantpopulations
AT carmerocasaumell evaluationoftheaccuracyofamultiinfectionscreeningtestbasedonamultipleximmunoassaytargetingimporteddiseasescommoninmigrantpopulations
AT marinagigantelopez evaluationoftheaccuracyofamultiinfectionscreeningtestbasedonamultipleximmunoassaytargetingimporteddiseasescommoninmigrantpopulations
AT oriolgasch evaluationoftheaccuracyofamultiinfectionscreeningtestbasedonamultipleximmunoassaytargetingimporteddiseasescommoninmigrantpopulations
AT gemmafalco evaluationoftheaccuracyofamultiinfectionscreeningtestbasedonamultipleximmunoassaytargetingimporteddiseasescommoninmigrantpopulations
AT anajimenezlozano evaluationoftheaccuracyofamultiinfectionscreeningtestbasedonamultipleximmunoassaytargetingimporteddiseasescommoninmigrantpopulations
AT angelamartinezperez evaluationoftheaccuracyofamultiinfectionscreeningtestbasedonamultipleximmunoassaytargetingimporteddiseasescommoninmigrantpopulations
AT consolsanchezcollado evaluationoftheaccuracyofamultiinfectionscreeningtestbasedonamultipleximmunoassaytargetingimporteddiseasescommoninmigrantpopulations
AT andreatedesco evaluationoftheaccuracyofamultiinfectionscreeningtestbasedonamultipleximmunoassaytargetingimporteddiseasescommoninmigrantpopulations
AT manuelcarloslopez evaluationoftheaccuracyofamultiinfectionscreeningtestbasedonamultipleximmunoassaytargetingimporteddiseasescommoninmigrantpopulations
AT mariajesuspinazo evaluationoftheaccuracyofamultiinfectionscreeningtestbasedonamultipleximmunoassaytargetingimporteddiseasescommoninmigrantpopulations
AT thaisleonel evaluationoftheaccuracyofamultiinfectionscreeningtestbasedonamultipleximmunoassaytargetingimporteddiseasescommoninmigrantpopulations
AT zenobisoffi evaluationoftheaccuracyofamultiinfectionscreeningtestbasedonamultipleximmunoassaytargetingimporteddiseasescommoninmigrantpopulations
AT annafarnert evaluationoftheaccuracyofamultiinfectionscreeningtestbasedonamultipleximmunoassaytargetingimporteddiseasescommoninmigrantpopulations
AT carlotadobano evaluationoftheaccuracyofamultiinfectionscreeningtestbasedonamultipleximmunoassaytargetingimporteddiseasescommoninmigrantpopulations
AT anarequenamendez evaluationoftheaccuracyofamultiinfectionscreeningtestbasedonamultipleximmunoassaytargetingimporteddiseasescommoninmigrantpopulations